UBS Group restated their buy rating on shares of ConvaTec Group (LON:CTEC – Free Report) in a research report released on Friday morning, MarketBeat reports. They currently have a GBX 375 target price on the stock.
Other equities analysts have also issued research reports about the stock. Berenberg Bank decreased their price objective on shares of ConvaTec Group from GBX 335 to GBX 330 and set a “buy” rating for the company in a research note on Tuesday, August 19th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a GBX 315 target price on shares of ConvaTec Group in a research report on Wednesday, July 30th. JPMorgan Chase & Co. reiterated an “overweight” rating on shares of ConvaTec Group in a report on Wednesday, July 30th. Peel Hunt reissued a “buy” rating and set a GBX 280 price target on shares of ConvaTec Group in a research report on Tuesday, October 28th. Finally, Royal Bank Of Canada raised ConvaTec Group to an “outperform” rating and reduced their price objective for the stock from GBX 320 to GBX 315 in a research note on Thursday, August 21st. Six investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of GBX 320.33.
View Our Latest Stock Report on CTEC
ConvaTec Group Trading Up 0.9%
Insider Buying and Selling
In other ConvaTec Group news, insider Jonny Mason acquired 50,000 shares of the business’s stock in a transaction that occurred on Thursday, August 28th. The shares were purchased at an average price of GBX 235 per share, with a total value of £117,500. Corporate insiders own 0.94% of the company’s stock.
ConvaTec Group Company Profile
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.
Read More
- Five stocks we like better than ConvaTec Group
- Large Cap Stock Definition and How to Invest
- Qualcomm Earnings Surprise Wall Street—Here’s What Q4 Could Deliver
- Canadian Penny Stocks: Can They Make You Rich?
- MarketBeat Week in Review – 11/03 – 11/07
- Asset Allocation Strategies in Volatile Markets
- OpenAI’s Restructuring Sets up What Could Be the Biggest IPO Ever
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.
